共 210 条
[1]
You EL(2023)Comparing interventions for chronic central serous chorioretinopathy: a network meta-analysis Surv Ophthalmol 101 140-159
[2]
Hébert M(2023)Comparative efficacy of treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses Acta Ophthalmol 33 309-315
[3]
Jin TS(2023)Comparing treatment outcomes in randomized controlled trials of central serous chorioretinopathy Graefes Arch Clin Exp Ophthalmol 33 316-323
[4]
Bourgault S(2013)Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study Retina 28 944-957
[5]
Caissie M(2013)Half-fluence photodynamic therapy in chronic central serous chorioretinopathy Retina 122 555-561
[6]
Tourville É(2014)Photodynamic therapy for central serous chorioretinopathy Eye (Lond) 256 2027-2034
[7]
Chen J(2015)One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy Ophthalmology 13 264-1078
[8]
Ordóñez-Mena J(2018)Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy Graefes Arch Clin Exp Ophthalmol 121 1073-1037
[9]
Dirani A(2020)Current pharmacological treatment options for central serous chorioretinopathy: a review Pharmaceuticals (Basel) 157 1033-690
[10]
van Dijk EHC(2014)Macula society CSC collaborative study group, research and education committee and website committee. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy Ophthalmology 5 685-2073